Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Willem de Laat, Lisa Pagan, R. Karl Malcolm, Maarten Wiegerinck, Victor Nickolson, Bertine Huisman, Rik Stuurman, Michiel van Esdonk & Naomi Klarenbeek. (2023) First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring. Drug Delivery 30:1.
Read now
Read now
Raúl Vozmediano-Chicharro, Pedro Blasco Hernández & Blanca Madurga-Patuel. (2020) Insights into the Management of Overactive Bladder with Transdermal Oxybutynin: A Practical Review. Research and Reports in Urology 12, pages 321-330.
Read now
Read now
Articles from other publishers (6)
Mahnoor F. Malik, Joseph Hogan Randall, Jack G. Campbell, Matthew J. McLaughlin & Joel F. Koenig. (2022) Dosing Variability and Clinical Outcomes of Oxybutynin: A Pediatric Cohort of Patients With Neurogenic Bladder. Topics in Spinal Cord Injury Rehabilitation 28:3, pages 9-14.
Crossref
Crossref
Jaroslav Tůma. (2021) Comparison of efficacy and side effects of anticholinergic drugs in treating overactive bladder syndrome. Urologie pro praxi 22:3, pages 115-119.
Crossref
Crossref
Raúl Vozmediano-Chicharro, Blanca Madurga & Pedro Blasco. (2018) Efficacy of Transdermal Oxybutynin in the Treatment of Overactive Bladder Syndrome: Does It Make Sense Using It in 2017?. Advances in Urology 2018, pages 1-7.
Crossref
Crossref
L.N. Plowright & G.W. Davila. 2015. Overactive Bladder. Overactive Bladder
91
99
.
A. Qarro, M. Asseban, K. Bazine, M. Najoui, J. Samir, Y. Ouhbi, A. Beddouch, M. Lezrek & M. Alami. (2014) Hyperactivité vésicale : physiopathologie et prise en charge. Journal de Réadaptation Médicale : Pratique et Formation en Médecine Physique et de Réadaptation 34:1, pages 23-34.
Crossref
Crossref
Oroma B. Nwanodi & Gil Levy. (2010) Overactive Bladder Syndrome. Postgraduate Obstetrics & Gynecology 30:12, pages 1-8.
Crossref
Crossref